Non-NSAID non-H. pylori ulcer disease

Best Practice and Research: Clinical Gastroenterology

Volumn 23, Issue 1, 2009, Pages 3-9

  Chow, Dorothy K L ^a   Sung, Joseph J Y ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Idiopathic gastroduodenal ulcer disease; Non NSAID non H. pylori ulcer

Indexed keywords

ACETYLSALICYLIC ACID; ANTACID AGENT; ANTITHROMBOCYTIC AGENT; BISMUTH; CYCLOOXYGENASE 2 INHIBITOR; HISTAMINE H2 RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR;

ARTICLE; CLINICAL PROTOCOL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DRUG EFFICACY; ERADICATION THERAPY; GASTRODUODENAL ULCER; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HIGH RISK PATIENT; HUMAN; MORTALITY; PATHOGENESIS; PEPTIC ULCER; PEPTIC ULCER BLEEDING; PREVALENCE; RECURRENT DISEASE; RISK ASSESSMENT;

AGE FACTORS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTI-ULCER AGENTS; HELICOBACTER PYLORI; HUMANS; PEPTIC ULCER; PEPTIC ULCER HEMORRHAGE; PREVALENCE; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 60949095478     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpg.2008.11.010     Document Type: Article

References (23)

1. Rockall T.A., Logan R.F., Devlin H.B., et al. Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom. Steering committee and members of the National Audit of Acute Upper Gastrointestinal Haemorrhage. BMJ 311 (1995) 222-226
2. NIH Consensus Development Panel. Helicobacter pylori in peptic ulcer disease. JAMA 272 (1994) 65-69
3. Marshall B.J., Goodwin C.S., Warren J.R., et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 2 (1988) 1437-1442
4. Graham D.Y., Lew G.M., Klein P.D., et al. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer: a randomized, controlled study. Ann Intern Med 116 (1992) 705-708
5. Sung J.J., Chung S.C., Ling T.K., et al. Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. N Engl J Med 332 (1995) 139-142
6. Tatsuta M., Iishi H., and Yokata Y. Effects of Helicobacter pylori infection on healing and recurrence of gastric ulcers. Am J Gastroenterol 90 (1995) 406-410
7. Chow D.K., and Sung J.J. Is the prevalence of idiopathic ulcers really on the increase?. Nat Clin Pract Gastroenterol Hepatol 4 (2007) 176-177
8. Silverstein F.E., Faich G., Goldstein J.L., et al. Gastrointestinal toxicity with celecoxib vs. nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib long-term arthritis safety study. JAMA 284 (2000) 1247-1255
9. Jyotheeswaran S., Shah A.N., Jin H.O., et al. Prevalence of Helicobacter pylori in peptic ulcer patients in greater Rochester, NY: is empirical triple therapy justified?. Am J Gastroenterol 93 (1998) 574-578
10. Ciociola A.A., McSorley D.J., Turner K., et al. Helicobacter pylori infection rates in duodenal ulcer patients in the United States may be lower than previously estimated. Am J Gastroenterol 94 (1999) 1834-1840
11. Laine L., Hopkins R.J., and Girardi L.S. Has the impact of Helicobacter pylori therapy on ulcer recurrence in the United States been overstated? A meta-analysis of rigorously designed trials. Am J Gastroenterol 93 (1998) 1409-1415
12. Graham D.Y., Hirschowitz B., Ciociola A.A., et al. Ranitidine bismuth citrate plus amoxicillin for the treatment of duodenal ulcer disease. Am J Gastroenterol 90 (1995) 1634
13. Peterson W.L., Ciociola A.A., Sykes D.L., et al. The RBC H. pylori Study Group Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcers, eradicating H. pylori, and reducing ulcer recurrence. Aliment Pharmacol Ther 10 (1996) 251-262
14. Lanza F., Ciociola A.A., Sykes D.L., et al. Ranitidine bismuth citrate plus clarithromycin is effective in eradicating H. pylori, healing duodenal ulcers, and preventing ulcer relapse. Gastroenterology 110 (1996) A172
15. Nishikawa K., Sugiyama T., Kato M., et al. Non-Helicobacter pylori and non-NSAID peptic ulcer disease in the Japanese population. Eur J Gastroenterol Hepatol 12 (2000) 635-640
16. Chan H.L.Y., Wu J.C.W., Chan F.K.L., et al. Is non-Helicobacter pylori, non-NSAID peptic ulcer a common cause of upper GI Bleeding? A prospective study of 977 patients. Gastrointest Endosc 53 (2001) 438-442
17. Hung L.C., Ching J.Y., Sung J.J., et al. Long-term outcome of Helicobacter pylori-negative idiopathic bleeding ulcers: a prospective cohort study. Gastroenterology 128 (2005) 1845-1850
18. McColl K.E., el-Nujumi A.M., Chittajallu R.S., et al. A study of the pathogenesis of Helicobacter pylori negative chronic duodenal ulceration. Gut 34 (1993) 762-768
19. Kamada T., Haruma K., Kusunoki H., et al. Significance of an exaggerated meal-stimulated gastrin response in pathogenesis of Helicobacter pylori-negative duodenal ulcer. Dig Dis Sci 48 (2003) 644-651
20. Leung W.K., Sung J.J., Siu K.L., et al. False-negative biopsy urease test in bleeding ulcers is due to buffering effects of blood. Am J Gastroenterol 93 (1998) 1914-1918
21. Gisbert J.P., and Abraira V. Accuracy of Helicobacter pylori diagnostic tests in patients with bleeding peptic ulcer: a systematic review and meta-analysis. Am J Gastroenterol 101 (2006) 848-863
22. Bytzer P., Teglbjaerg P.S., and The Danish Ulcer Study Group. Helicobacter pylori-negative duodenal ulcers (prevalence, clinical characteristics, and prognosis - results from a randomised trial with 2-year follow-up). Am J Gastroenterol 96 (2001) 1409-1416
23. Wong G.L.H., Ching J.Y.L., Chan Y., et al. Long-term outcome of Helicobacter pylori-negative idiopathic bleeding ulcers: a 7-year prospective cohort study. Gastroenterology 134 (2008) (Suppl 1):A75